Literature DB >> 10871875

IFN-alpha and IFN-beta: a link between immune memory and chronic inflammation.

A N Akbar1, J M Lord, M Salmon.   

Abstract

The majority of expanded T cells generated during an immune response are cleared by apoptosis. Prevention of death in some activated T cells enables the persistence of a memory T-cell pool. Here, observations that IFN-alpha and IFN-beta inhibit activated T-cell apoptosis are described. Although this enables memory T cells to persist without antigen, excessive IFN-alpha or IFN-gamma secretion might lead to chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871875     DOI: 10.1016/s0167-5699(00)01652-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  29 in total

1.  Dramatic response to granulocytapheresis in a Crohn's disease case complicated by hepatitis C virus.

Authors:  Koji Sawada; Kunio Ohnishi; Takeshi Kusaka; Yoshika Matoba; Ken Fukunaga
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

2.  Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.

Authors:  Kristina Abel; Bapi Pahar; Koen K A Van Rompay; Linda Fritts; Clarissa Sin; Kimberli Schmidt; Roxana Colón; Mike McChesney; Marta L Marthas
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.

Authors:  K L DeCicco; J D Youngdahl; A C Ross
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

4.  The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life.

Authors:  O Vosters; C Lombard; F André; G Sana; E M Sokal; F Smets
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

5.  IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder.

Authors:  Hamid Fallah; Arezou Sayad; Fatemeh Ranjbaran; Fatemeh Talebian; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2019-11-14       Impact factor: 3.584

6.  Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.

Authors:  G Coma; R Peña; J Blanco; A Rosell; F E Borras; J A Esté; B Clotet; L Ruiz; R M E Parkhouse; M Bofill
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

7.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

8.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques.

Authors:  D M Asmuth; K Abel; M D George; S Dandekar; R B Pollard; C J Miller
Journal:  J Med Primatol       Date:  2008-02       Impact factor: 0.667

10.  Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA.

Authors:  Christian D Sadik; Malte Bachmann; Josef Pfeilschifter; Heiko Mühl
Journal:  Nucleic Acids Res       Date:  2009-06-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.